Nothing Special   »   [go: up one dir, main page]

EA201892425A1 - HETEROCYCLIC AMIDES SUITABLE AS MODELS OF PROTEINS - Google Patents

HETEROCYCLIC AMIDES SUITABLE AS MODELS OF PROTEINS

Info

Publication number
EA201892425A1
EA201892425A1 EA201892425A EA201892425A EA201892425A1 EA 201892425 A1 EA201892425 A1 EA 201892425A1 EA 201892425 A EA201892425 A EA 201892425A EA 201892425 A EA201892425 A EA 201892425A EA 201892425 A1 EA201892425 A1 EA 201892425A1
Authority
EA
Eurasian Patent Office
Prior art keywords
proteins
models
heterocyclic amides
amides suitable
heterocyclic
Prior art date
Application number
EA201892425A
Other languages
Russian (ru)
Other versions
EA036338B1 (en
Inventor
Адам Кеннет Чарнли
Майкл Г. Дарси
Джейсон У. Додсон
Сяоян Дун
Терри В. Хьюз
Цзяньсин Кан
Лара Кэтрин Лейстер
Ицянь Лянь
Юэ Ли
Джон Ф. Мелманн
Нейса Невинс
Джоши М. Раманджулу
Джозеф Дж. Романо
Грен З. Ван
Госэнь Е
Даохуа Чжан
Original Assignee
Глэксосмитклайн Интеллекчуал Проперти Девелопмент Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глэксосмитклайн Интеллекчуал Проперти Девелопмент Лимитед filed Critical Глэксосмитклайн Интеллекчуал Проперти Девелопмент Лимитед
Publication of EA201892425A1 publication Critical patent/EA201892425A1/en
Publication of EA036338B1 publication Critical patent/EA036338B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Раскрыты соединения, имеющие формулугде q, r, s, A, B, C, R, R, R, R, R, R, R, R, R, R, R, R, Rи Rимеют значения, определенные здесь, или его таутомер, или соль, в частности его фармацевтически приемлемая соль.Compounds having the formula q, r, s, A, B, C, R, R, R, R, R, R, R, R, R, R, R, R and R are as defined herein, or tautomer, or salt, in particular its pharmaceutically acceptable salt.

EA201892425A 2017-02-22 2017-04-05 Heterocyclic amides useful as protein modulators EA036338B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762461975P 2017-02-22 2017-02-22

Publications (2)

Publication Number Publication Date
EA201892425A1 true EA201892425A1 (en) 2019-04-30
EA036338B1 EA036338B1 (en) 2020-10-28

Family

ID=66436947

Family Applications (3)

Application Number Title Priority Date Filing Date
EA201892261A EA036435B1 (en) 2017-02-22 2017-04-05 Heterocyclic amides useful as protein modulators
EA201892424A EA037671B1 (en) 2017-02-22 2017-04-05 Heterocyclic amides useful as protein modulators
EA201892425A EA036338B1 (en) 2017-02-22 2017-04-05 Heterocyclic amides useful as protein modulators

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EA201892261A EA036435B1 (en) 2017-02-22 2017-04-05 Heterocyclic amides useful as protein modulators
EA201892424A EA037671B1 (en) 2017-02-22 2017-04-05 Heterocyclic amides useful as protein modulators

Country Status (1)

Country Link
EA (3) EA036435B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114174303A (en) * 2019-07-22 2022-03-11 印度鲁宾有限公司 Macrocyclic compounds as STING agonists, methods and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091446A1 (en) * 2010-01-22 2011-07-28 Glaxosmithkline Llc Chemical compounds
US20140364617A1 (en) * 2010-12-15 2014-12-11 Abbvie Inc. Anti-viral compounds
SG11201609021QA (en) * 2014-06-04 2016-11-29 Glaxosmithkline Ip Dev Ltd Cyclic di-nucleotides as modulators of sting

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114174303A (en) * 2019-07-22 2022-03-11 印度鲁宾有限公司 Macrocyclic compounds as STING agonists, methods and uses thereof

Also Published As

Publication number Publication date
EA201892261A1 (en) 2019-04-30
EA037671B1 (en) 2021-04-29
EA201892424A1 (en) 2019-04-30
EA036338B1 (en) 2020-10-28
EA036435B1 (en) 2020-11-10

Similar Documents

Publication Publication Date Title
EA201892128A1 (en) HETEROCYCLIC AMIDES USEFUL AS MODULATORS
PH12018502202A1 (en) Heterocyclic amides useful as protein modulators
CY1124187T1 (en) HETEROCYCLIC AMIDES AS KINASE INHIBITORS
EA201691913A1 (en) SUBSTITUTED [1,2,4] TRIAZOL AND IMIDAZOL COMPOUNDS AS FUNGICIDES
PH12017550004B1 (en) Heterocyclic derivatives and use thereof
MX2018009459A (en) Sulfonamide derivative and pharmaceutical composition containing same.
EA201790627A1 (en) STEMULATORS RHC
EA201790432A1 (en) PROBES FOR VISUALIZATION PROTEIN HANTINGTIN
DK3625224T3 (en) N-SUBSTITUTED CONTENT DERIVATIVES
EA201691412A1 (en) HYDROXYFORMAMIDE DERIVATIVES AND THEIR APPLICATION
DK3560925T3 (en) Novel compound and pharmaceutically acceptable salt thereof
EA201691566A1 (en) APPLICATION OF PYRIDAZIN DERIVATIVES FOR THE PREVENTION OR TREATMENT OF THE ATTAXIC SYNDROME
EA201990313A1 (en) DERIVATIVE TRIAZOLOPYRAZINONE USED AS A HUMAN PDE1 INHIBITOR
MY180727A (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzeimer?s disease
EA201892425A1 (en) HETEROCYCLIC AMIDES SUITABLE AS MODELS OF PROTEINS
DK3472149T3 (en) HETEROCYCLIC PROLINE MID DERIVATIVES
EA201991141A1 (en) AMPLIFIERS BMP
EA201990506A1 (en) PHARMACEUTICAL COMPOSITION
UA39587S (en) WARDROBE
IT201800009293A1 (en) "SOFA"
IT201700033290A1 (en) "IMPROVED BED"
UA114966U (en) APPLICATION OF SODIUM SALT [POLY- (2,5-Dihydroxyphenylene)] - 4-THIOSULPHOXYLES FOR TREATMENT OF ACUTE KIDNEY INJURY